Active Stocks Healthcare: Arena Pharmaceuticals (NASDAQ:ARNA), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA)

Arena Pharmaceuticals Inc (NASDAQ: ARNA ) and VIVUS (NASDAQ: VVUS ) in early 2012 as each company headed into their regulatory reviews with the U.S. Food and Drug Administration, or FDA, for their respective obesity medications. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was -2.84% in last session and finished the day at $6.49. Traded volume was 6.83million shares in the last session and the average … Continue reading Active Stocks Healthcare: Arena Pharmaceuticals (NASDAQ:ARNA), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA)

Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

CytRx Corporation (NASDAQ:CYTR) reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -12.76% in last session and finished the day at $4.17. Traded volume was 11,065,087 million shares in the last session and the average volume of the stock remained 3.51 … Continue reading Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Biotech Runners: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

VIVUS Inc. (NASDAQ:VVUS) stock was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $8.00 price target on the stock, down previously from $15.00. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 1.00% in last session and finished the day at $6.09. Traded volume was 5,364,675 million shares in the last session and the average volume … Continue reading Biotech Runners: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD)

Sizzling Stocks: Kinder Morgan, Inc. (NYSE:KMI), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Johnson Controls Inc. (NYSE:JCI), American Express Company (NYSE:AXP), eBay Inc. (NASDAQ:EBAY)

Kinder Morgan, Inc. (NYSE:KMI) will spend $3 billion to buy a new oil pipeline and other energy assets in the Bakken Shale from a private partnership controlled by oil billionaire Harold Hamm. Kinder Morgan, Inc. (NYSE:KMI) belongs to Basic Materials sector. Its net profit margin is 7.60% and weekly performance is 2.71%. On last trading day company shares ended up $42.00. Kinder Morgan, Inc. (NYSE:KMI) … Continue reading Sizzling Stocks: Kinder Morgan, Inc. (NYSE:KMI), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Johnson Controls Inc. (NYSE:JCI), American Express Company (NYSE:AXP), eBay Inc. (NASDAQ:EBAY)

Notable Moves: Martin Midstream Partners LP (NASDAQ:MMLP), Bank of America Corporation (NYSE:BAC), BP p.l.c. (NYSE:BP), Barrett Business Services (NASDAQ:BBSI), Arena Pharmaceuticals (NASDAQ:ARNA)

Martin Midstream Partners L.P. (NASDAQ:MMLP) has earned a consensus recommendation of “Hold” from the seven analysts that are currently covering the company, Analyst Ratings Net reports. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Martin Midstream Partners LP (NASDAQ:MMLP) belongs to Basic Materials sector. Its net profit margin is -3.00% and weekly … Continue reading Notable Moves: Martin Midstream Partners LP (NASDAQ:MMLP), Bank of America Corporation (NYSE:BAC), BP p.l.c. (NYSE:BP), Barrett Business Services (NASDAQ:BBSI), Arena Pharmaceuticals (NASDAQ:ARNA)

Stocks Getting Investor’s Attention: Arena Pharmaceuticals (NASDAQ:ARNA), Oasis Petroleum (NYSE:OAS), The Royal Bank of Scotland (NYSE:RBS), WisdomTree Investments (NASDAQ:WETF), BPT

On Jan 08, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced encouraging top-line results from a phase Ib study (n=50) on APD334 being developed for the treatment of autoimmune diseases. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is 51.25%. On last trading day company shares ended up $5.43. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is 31.40%. Hedge fund SPO … Continue reading Stocks Getting Investor’s Attention: Arena Pharmaceuticals (NASDAQ:ARNA), Oasis Petroleum (NYSE:OAS), The Royal Bank of Scotland (NYSE:RBS), WisdomTree Investments (NASDAQ:WETF), BPT